Bacteria News and Research

RSS

Flowers can uplift patients’ mood and reduce pain and anxiety

Does flower water harbour potentially deadly bacteria? Do bedside blooms compete with patients for oxygen? Do bouquets pose a health and safety risk around medical equipment?

17 Dec 2009

Pistachios can decrease inflammation and cardiovascular disease

New research published online, December 10, 2009 indicates that bioactive compounds in pistachios, and molecules present in pistachios, have anti-inflammatory properties.

17 Dec 2009

Scientists draw on bacterial decision-making success to guide human choices on H1N1 vaccine

Bacteria inhabited our planet for more than 4 billion years before humans showed up, and they'll probably outlive us by as many eons more. That suggests they may have something to teach us.

17 Dec 2009

Positive results from Onset Therapeutics' BenzEFoam Emollient Foam skin moisturization study

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced positive results from a skin moisturization study that compared the Company’s recently launched BenzEFoam™ (benzoyl peroxide 5.3%) Emollient Foam to a market leading combination gel containing clindamycin 1% - benzoyl peroxide 5%. BenzEFoam™ Emollient Foam is indicated for the topical treatment of mild to moderate acne vulgaris and is the first prescription foam formulation containing benzoyl peroxide as the active ingredient.

16 Dec 2009

Englerin A possesses high toxicity for kidney cancer cells, researchers discover

Englerin A, a natural product recently discovered in an African plant, possesses high toxicity for kidney cancer cells but low toxicity for other cells. Therefore this compound is potentially qualified for further evaluation toward an application in cancer therapy.

16 Dec 2009

Rib-X Pharmaceuticals and MGH enter into collaborative research agreement

Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections announced today it has entered into a collaborative research agreement with Massachusetts General Hospital (MGH).

16 Dec 2009

Advanced Plasma Products launches its new TriClean Pro air sanitizer

Applied Science Products, Inc., announced today that its wholly owned subsidiary, Advanced Plasma Products Inc., has introduced its new TriClean Pro air sanitizer product powered by the company's newest advanced plasma generator design.

15 Dec 2009

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Dr. Bob Arnot kicks-off a national educational tour on the silent threat of H1N1 flu contaminated touch surfaces and the new biotechnology in EPA-registered SpectraSan 24 that kills bacteria, fungus and viruses including Influenza A (H1N1 or Swine Flu).

15 Dec 2009

Freie Universität professor receives ERC grant for bacterial biofilm formation study

Prof. Dr. Regine Hengge at the Department of Biology, Chemistry, and Pharmacy at Freie Universität Berlin has been awarded funding from the European Research Council (ERC) for her research project to investigate the formation of bacterial biofilms. Hengge will receive an ERC Advanced Investigator Grant in an amount of up to two million euros.

15 Dec 2009

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

AcroMetrix, a leading provider of quality control standards for clinical diagnostic laboratories, announced today the launch of the first standardized quality control for MSSA molecular testing.

15 Dec 2009

Study supports the use of SinoFresh Nasal Spray to prevent and decrease H1N1 virus

SinoFresh HealthCare Products, Inc. announced the recent successful initial pilot animal study of the SinoFresh Nasal Spray product for use in preventing and decreasing the severity of H1N1 ("swine flu") virus.

14 Dec 2009

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist’s US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.

14 Dec 2009

By understanding how gene works, scientists may find ways to prevent, cure diabetes

A gene commonly studied by cancer researchers has been linked to the metabolic inflammation that leads to diabetes.

12 Dec 2009

Nutritional supplements to strengthen immunity and improve periodontal health

The PA periodontists in Dr. David DiGiallorenzo's Collegeville and Williamsport practice recently began offering two lines of nutritional supplements to patients as a means of promoting the connection between good nutrition and improved periodontal health.

11 Dec 2009

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) approved Cequent's first IND (investigational new drug) application yesterday.

10 Dec 2009

Public health information website to provide information about advanced disinfectants launched

TouchSurfaces.Org launches a public health information website alerting visitors on how the hard surfaces in the home, the work place, and in public venues can act as host to a multitude of infectious viruses and bacteria including H1N1, MRSA, HIV, and others.

10 Dec 2009

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today released an independent laboratory report indicating that the company's BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against the H1N1 virus.

10 Dec 2009

Patients' urine may provide rapid diagnosis of pneumonia

Doctors may soon be able to quickly and accurately diagnose the cause of pneumonia-like symptoms by examining the chemicals found in a patient's urine, suggests a new study led by UC Davis biochemist Carolyn Slupsky.

10 Dec 2009

Scientists discover the potential basis for urine test to diagnose CAP

Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.

10 Dec 2009

Pharma IQ to organize Anti-Infectives Summit in Philadelphia

Organized by Pharma IQ, a division of IQPC, the Anti-Infectives Summit will be held January 25-27, 2010 in Philadelphia, PA (www.anti-infectivesummit.com). This forum explores recent advances within anti-infective drug discovery and development, and is geared towards Chief Scientific Officers and Scientists working in microbiology, immunology, infectious diseases, medicinal chemistry and drug development.

From IQPC Ltd 10 Dec 2009

Bacteria News and Research

Flowers can uplift patients’ mood and reduce pain and anxiety

Pistachios can decrease inflammation and cardiovascular disease

Scientists draw on bacterial decision-making success to guide human choices on H1N1 vaccine

Positive results from Onset Therapeutics' BenzEFoam Emollient Foam skin moisturization study

Englerin A possesses high toxicity for kidney cancer cells, researchers discover

Rib-X Pharmaceuticals and MGH enter into collaborative research agreement

Advanced Plasma Products launches its new TriClean Pro air sanitizer

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Freie Universität professor receives ERC grant for bacterial biofilm formation study

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

Study supports the use of SinoFresh Nasal Spray to prevent and decrease H1N1 virus

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

By understanding how gene works, scientists may find ways to prevent, cure diabetes

Nutritional supplements to strengthen immunity and improve periodontal health

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Public health information website to provide information about advanced disinfectants launched

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Patients' urine may provide rapid diagnosis of pneumonia

Scientists discover the potential basis for urine test to diagnose CAP

Pharma IQ to organize Anti-Infectives Summit in Philadelphia

Microbiology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News